Research by Public Health England (PHE), which monitors vaccine effectiveness within the UK, shows that those who become infected 3 weeks after receiving one dose of the Pfizer-BioNTech (Cominarty) or AstraZeneca (Vaxzevria) vaccine were between 38% and 49% less likely to pass COVID-19 on to their household contacts than those who were unvaccinated.